WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 12'6401 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 19'9641 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 89  88  87  86  85  78  62  70 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years 23  23  23  23  23  23  18  24 
Female 15-49 years 26  25  25  25  25  23  17  19 

Number of reported case

(Click for retrospective incidence data for Antigua and Barbuda)
Diphtheria
Japanese encephalitis
Measles 2'291 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Antigua and Barbuda)
Vaccine year result method % card seen                                                
BCG          99 
DTP1          90  75  90  100  99* 
DTP3          98  99  98  99  99*  95  99  54 
HepB_BD         
HepB3          98  99  98  98  99* 
Hib3          98  99  98  94  99* 
JapEnc         
MCV          98  100  98  99  99*  95  89 
MCV2          90  89  94  83 
PCV1         
PCV3          10 
Pol3          97  99  99  98  100  96  99  36 
Rota1         
Rota_last         
Rubella1          100  100  98  99  99* 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Antigua and Barbuda)
DTP1 99  99  99  99  99  98  99  77 
DTP3 98  99  98  99  99  95  99  54 
HepB3 98  99  98  98  98 
Hib3 98  98  98  94  97 
MCV 98  99  98  99  99  95  89 
PCV3
Pol3 97  99  99  98  99  96  99  36 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT 18 months; 4-5, 15 years; Yes
DTwP 18 months; Yes
DTwPHibHep 2, 4, 6 months;
HepB 1st contact; +6 weeks; +6 months;
Influenza 6-35 months; Yes and adults
MMR 12 months; 4-5, 15 years; Yes
OPV 2, 4, 6, 18 months; 4-5 years; Yes
Td 1st contact; + 6 weeks; +6 months; Yes every 10 years

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  No  No  No  No  No  No 
What years does the MYP cover? number 2'012            NA 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number   27  24  26 
Nº districts with DTP3 coverage >=80% number   20   
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100      83   
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100         

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100      100  100    100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.